Edwards Lifesciences Corp.

NYS: EW

GO
/marketstate/country/us

After Hours

 --Real time quotes

Nov 24, 2020, 4:01 p.m.

EW
/zigman2/quotes/205745196/composite

$

85.61

Change

-0.04 -0.05%

Volume

Volume 84,876

Real time quotes

/zigman2/quotes/205745196/composite

Today's close

$ 84.70

$ 85.65

Change

+0.95 +1.12%

Day low

Day high

$85.01

$86.15

Open

52 week low

52 week high

$51.51

$88.00

Open

Insider Actions for Edwards Lifesciences Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
98,550   Derivative/Non-derivative trans. at $13.98 per share. 1,377,729
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
35,205   Disposition at $85.19 per share. 2,999,113
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
30,345   Disposition at $84.82 per share. 2,573,862
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
2,400   Disposition at $86.51 per share. 207,624
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
600   Disposition at $87.37 per share. 52,422
11/17/2020 Michael A. Mussallem
Chairman & CEO; Director
30,000   Gift at $0 per share. 0
11/16/2020 Steven R. Loranger
Director
19,797   Derivative/Non-derivative trans. at $35.2 per share. 696,854
11/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
12,213   Disposition at $80.52 per share. 983,390
11/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
861   Disposition at $81.09 per share. 69,818
11/13/2020 Donald E. Bobo
CVP,Strategy/Corp Development
13,074   Derivative/Non-derivative trans. at $13.98 per share. 182,774
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
8,290   Disposition at $81.01 per share. 671,572
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
3,359   Disposition at $81.76 per share. 274,631
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
81   Disposition at $81.76 per share. 6,622
11/11/2020 Huimin Wang
CVP, Japan & Intercontinental
11,649   Derivative/Non-derivative trans. at $13.98 per share. 162,853
11/09/2020 Donald E. Bobo
CVP,Strategy/Corp Development
227   Disposition at $83.88 per share. 19,040
11/06/2020 Donald E. Bobo
CVP,Strategy/Corp Development
347   Disposition at $78.01 per share. 27,069
11/02/2020 Larry L. Wood
CVP, TAVR
10,698   Disposition at $73.27 per share. 783,842
11/02/2020 Larry L. Wood
CVP, TAVR
10,698   Derivative/Non-derivative trans. at $21.76 per share. 232,788
10/29/2020 Catherine M. Szyman
CVP, Critical Care
20,355   Disposition at $73.24 per share. 1,490,800
10/29/2020 Catherine M. Szyman
CVP, Critical Care
20,355   Derivative/Non-derivative trans. at $22.29 per share. 453,712
10/26/2020 Scott B. Ullem
CVP, Chief Financial Officer
19,229   Disposition at $79.2 per share. 1,522,936
10/26/2020 Scott B. Ullem
CVP, Chief Financial Officer
13,921   Disposition at $78.26 per share. 1,089,457
10/26/2020 Scott B. Ullem
CVP, Chief Financial Officer
33,150   Derivative/Non-derivative trans. at $21.76 per share. 721,344
10/12/2020 Scott B. Ullem
CVP, Chief Financial Officer
27,500   Disposition at $83.69 per share. 2,301,475
10/12/2020 Scott B. Ullem
CVP, Chief Financial Officer
5,650   Disposition at $84.37 per share. 476,690
10/12/2020 Scott B. Ullem
CVP, Chief Financial Officer
33,150   Derivative/Non-derivative trans. at $21.76 per share. 721,344

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
23 Purchases
40 Sales
712,905
611,128
Last 6 months
43 Purchases
79 Sales
1,323,729
1,159,806
Last 12 months
110 Purchases
189 Sales
1,795,404
1,518,712

Officers and Executives

Mr. Michael A. Mussallem
Chairman & Chief Executive Officer
Mr. Scott B. Ullem
Chief Financial Officer & Vice President
Dr. John P. McGrath
Vice President-Quality, Regulatory & Clinical
Dr. Todd J. Brinton
Chief Scientific Officer & VP-Advanced Technology
Mr. Jean-Luc Lemercier
Corporate Vice President
Mr. Larry L. Wood
Vice President-Transcatheter Aortic Valve
Dr. Huimin Wang
Vice President-Japan, Asia & Pacific Region
Mr. Donald E. Bobo
Vice President-Strategy & Corporate Development
Mr. Bernard J. Zovighian
Vice President-Transcatheter Mitral
Ms. Catherine M. Szyman
Vice President-Critical Care Business
Mr. Daveen Chopra
Vice President-Surgical Structural Heart
Ms. Ramona Sequeira
Director
Mr. Paul Arthur LaViolette
Director
Mr. Tim Patz
Vice President-Global Marketing
Mr. Robert W. A. Sellers
Vice President & Controller
Mr. Mark A. Wilterding
Investor Contact
Ms. Christine Z. McCauley
Vice President-Human Resources
Ms. Linda J. Park
Secretary, Associate General Counsel & VP
Mr. Arnold A. Pinkston
Vice President & General Counsel
Ms. Tammy Perry
Senior Manager-Investor Relations
Dr. William J. Link
Independent Director
Dr. Nicholas J. Valeriani
Independent Director
Mr. Kieran T. Gallahue
Independent Director
Ms. Martha H. Marsh
Lead Independent Director
Mr. Steven R. Loranger
Independent Director
Ms. Leslie Stone Heisz
Independent Director
Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.